Bhi Throat

Silver Nitrate, Arnica Montana Root, Arisaema Triphyllum Root, Oyster Shell Calcium Carbonate, Crude,activated Charcoal, Causticum, Hyoscyamus Niger, Paris Quadrifolia, Phosphorus, And Verbascum Thapsus

Medinatura Inc
Human Otc Drug
NDC 62795-1014

Bhi Throat also known as Silver Nitrate, Arnica Montana Root, Arisaema Triphyllum Root, Oyster Shell Calcium Carbonate, Crude,activated Charcoal, Causticum, Hyoscyamus Niger, Paris Quadrifolia, Phosphorus, And Verbascum Thapsus is a human otc drug labeled by 'Medinatura Inc'. National Drug Code (NDC) number for Bhi Throat is 62795-1014. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Bhi Throat drug includes Activated Charcoal - 10 [hp_X]/1 Arisaema Triphyllum Root - 4 [hp_X]/1 Arnica Montana Root - 8 [hp_X]/1 Causticum - 6 [hp_X]/1 Hyoscyamus Niger - 6 [hp_X]/1 Oyster Shell Calcium Carbonate, Crude - 30 [hp_X]/1 Paris Quadrifolia - 5 [hp_X]/1 Phosphorus - 10 [hp_X]/1 Silver Nitrate - 6 [hp_X]/1 Verbascum Thapsus - 8 [hp_X]/1 . The currest status of Bhi Throat drug is Active.

Drug Information:

Drug NDC:	62795-1014
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Bhi Throat
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Silver Nitrate, Arnica Montana Root, Arisaema Triphyllum Root, Oyster Shell Calcium Carbonate, Crude,activated Charcoal, Causticum, Hyoscyamus Niger, Paris Quadrifolia, Phosphorus, And Verbascum Thapsus
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Medinatura Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACTIVATED CHARCOAL - 10 [hp_X]/1 ARISAEMA TRIPHYLLUM ROOT - 4 [hp_X]/1 ARNICA MONTANA ROOT - 8 [hp_X]/1 CAUSTICUM - 6 [hp_X]/1 HYOSCYAMUS NIGER - 6 [hp_X]/1 OYSTER SHELL CALCIUM CARBONATE, CRUDE - 30 [hp_X]/1 PARIS QUADRIFOLIA - 5 [hp_X]/1 PHOSPHORUS - 10 [hp_X]/1 SILVER NITRATE - 6 [hp_X]/1 VERBASCUM THAPSUS - 8 [hp_X]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Jan, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	30 Apr, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	13 Jun, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	MediNatura Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	2P3VWU3H10 DM64K844DM MUE8Y11327 DD5FO1WKFU 4WRK2153H3 2E32821G6I PME3ETQ5WQ 27YLU75U4W 95IT3W8JZE C9TD27U172
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
62795-1014-3	1 BOTTLE in 1 CARTON (62795-1014-3) / 100 TABLET in 1 BOTTLE	01 Jan, 2015	30 Apr, 2026	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Bhi Throat

Silver Nitrate & more..

Tablet
MediNatura Inc
NDC: 62795-1014

Purpose:

Purpose sore throat relief tablets relieves: â¢ sore throat â¢ scratchiness â¢ minor irritation

Product Elements:

Bhi throat silver nitrate, arnica montana root, arisaema triphyllum root, oyster shell calcium carbonate, crude,activated charcoal, causticum, hyoscyamus niger, paris quadrifolia, phosphorus, and verbascum thapsus silver nitrate silver cation arnica montana root arnica montana root arisaema triphyllum root arisaema triphyllum root oyster shell calcium carbonate, crude oyster shell calcium carbonate, crude activated charcoal activated charcoal causticum causticum hyoscyamus niger hyoscyamus niger paris quadrifolia paris quadrifolia phosphorus phosphorus verbascum thapsus verbascum thapsus lactose magnesium stearate maltodextrin dextrose leafman

Indications and Usage:

Uses for the temporary relief of minor sore throat, throat scratchiness, throat irritation

Warnings:

Warnings if pregnant or breast-feeding , ask a health professional before use. keep out of reach of children. if symptoms persist or worsen, a health professional should be consulted. severe or persistent sore throat accompanied by high fever, headache, nausea, and vomiting may be serious. consult physician promptly. do not use more than 2 days or administer to children under 4 years of age unless directed by a physician. stop and ask a doctor if irritation, pain or redness persists or worsens, or if swelling, rash or fever develops. do not use if known sensitivity to throat or any of its ingredients exists.

Dosage and Administration:

Directions at first sign of symptoms: adults and children 4 years and older: 1 tablet every 1/2 to 1 hour until symptoms lessen, then continue with standard dosage. standard dosage: adults and children 4 years and older: take 1-2 tablets every 4 to 6 hours. do not exceed 12 tablets in 24 hours. for children under 4, consult your health professional. allow tablets to dissolve completely in the mouth, do not swallow .

Package Label Principal Display Panel:

Bhi throat tablet.jpg

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.